![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1525258
¼¼°èÀÇ ¹«¼± ½ÉÀå ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð Á¶»ç : À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)Global Wireless Cardiac Monitoring Systems Market Size study, by Type (Implantable Cardiac Monitors, Patch-Type Monitor, Mobile Cardiac Telemetry System, Others), by End-use and Regional Forecasts 2022-2032 |
¼¼°è ¹«¼± ½ÉÀå ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀº 2023³â 29¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 11.4% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿þ¾î·¯ºí ¼¾¼¿Í ¸ð¹ÙÀÏ ¾ÛÀ¸·Î ±¸¼ºµÈ ¹«¼± ½ÉÀå ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº ȯÀÚÀÇ ½ÉÀå Ȱµ¿À» Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϰí ÀÇ·áÁø¿¡°Ô ¹«¼±À¸·Î µ¥ÀÌÅ͸¦ Àü¼ÛÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ºÎÁ¤¸ÆÀ» °¨ÁöÇϰí, ¸¸¼º ½ÉÀå ÁúȯÀ» °ü¸®Çϰí, ¼ö¼ú ÈÄ È¸º¹À» ¸ð´ÏÅ͸µÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ÀæÀº º´¿ø ¹æ¹®ÀÇ Çʿ伺À» ÃÖ¼ÒÈÇÒ ¼ö ÀÖ½À´Ï´Ù.
½ÉÇ÷°ü Áúȯ(CVD)¿¡ Ãë¾àÇÑ Àα¸ÀÇ °í·ÉÈ, ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼úÀÇ ±â¼ú ¹ßÀü, ½ÅÈï °æÁ¦±¹¿¡¼ÀÇ Á¦Ç° ½ÂÀÎ Áõ°¡·Î ÀÎÇØ ½ÃÀåÀº Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, ¿µ±¹½ÉÀåÀç´Ü(British Heart Foundation)Àº 2021³â Àü ¼¼°è ½ÉÀå ¹× ¼øÈ¯±â Áúȯ À¯º´·üÀÌ 6¾ï 2,000¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ̸ç, ½É¹æ¼¼µ¿Àº ÀÌ Áß ¾à 10%¸¦ Â÷ÁöÇÒ °ÍÀ̶ó°í º¸°íÇß½À´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â¼úÀÇ Çõ½ÅÀº ½ÃÀåÀ» ¹ßÀü½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾÷°è ±â¾÷µéÀº ÀÚ±Ý Áö¿ø, Á¦ÈÞ µî Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ º¥´õ Á߸³ÀûÀÎ ½ÉÀå µ¥ÀÌÅÍ °ü¸® Ç÷§ÆûÀ» °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷§ÆûÀº À̽ÄÇü ½ÉÀå ¸ð´ÏÅÍ(ICM), ¿þ¾î·¯ºí ±â±â, ¼ÒºñÀÚ ECG ±â±â µîÀ¸·ÎºÎÅÍ ÀÇ·á Á¤º¸¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ Ç÷§Æû¿¡ ÀΰøÁö´É(AI)À» ÅëÇÕÇÏ¿© ÀüÀÚ ÀÇ·á±â·ÏÀ» µ¿±âÈÇϰí, ±ä±ÞÇÑ È¯ÀÚ º¸°í ¹× Áß¿äÇÑ ½ÉÀå ¸®µëÀ» ½Äº°ÇÒ ¼ö ÀÖ¾î ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 7¿ù ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ¼ºñ½º Á¦°ø¾÷üÀÎ ÆäÀ̽º¸ÞÀÌÆ®(PaceMate)´Â ½ÉÀå ¼Ö·ç¼Ç°ú Àα¸ Åë°èÇÐÀû µµ´Þ ¹üÀ§¸¦ °ÈÇϱâ À§ÇØ ¸®µå¿§Áö ijÇÇÅ»(Lead Edge Capital)·ÎºÎÅÍ ÅõÀÚ¸¦ ¹Þ¾Ò½À´Ï´Ù.
ºÏ¹Ì°¡ 2023³â ¼¼°è ¹«¼± ½ÉÀå ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå Á¡À¯À² 48.53%¸¦ Â÷ÁöÇÏ¸ç ¼¼°è ¹«¼± ½ÉÀå ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â ÀÌ Áö¿ªÀÇ ¼±Áø ÀÇ·á ÀÎÇÁ¶ó, ½ÉÇ÷°ü ÁúȯÀÇ ³ôÀº À¯º´·ü, ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü, ¸·´ëÇÑ ÀÇ·áºñ, ³ëÀÎ Àα¸ Áõ°¡¿¡ ±âÀÎÇϸç, Rural Health Information Hub¿¡ µû¸£¸é 2020³â¿¡¼ 2030³â »çÀÌ¿¡ ¹Ì±¹ ³ëÀÎ Àα¸°¡ 1,800¸¸ ¸í Áõ°¡ÇÏ¿© 65¼¼ ÀÌ»ó ¼ºÀÎÀÇ 90%°¡ ÇÑ °¡Áö ÀÌ»óÀÇ ¸¸¼º ÁúȯÀ» ¾ÎÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ CAGRÀº ¿¹Ãø ±â°£ µ¿¾È 13.5%·Î °¡Àå ºü¸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¿øµ¿·ÂÀº Áß±¹, ÀϺ»°ú °°Àº ±¹°¡¿¡¼ÀÇ Á¦Ç° ½ÂÀÎ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 1¿ù ¹ÙÀÌ¿ÀÆ®·Î´Ð(Biotronik SE &Co.KG)Àº ÀÇ·á Àü¹®°¡°¡ ±âÃÊ ºÎÁ¤¸ÆÀ» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â À̽ÄÇü ½ÉÀå ¸ð´ÏÅÍ(ICM) BioMonitor III¸¦ ÀϺ»¿¡¼ Ãâ½ÃÇß½À´Ï´Ù. ¸¶Âù°¡Áö·Î 2021³â 10¿ù, »óÇÏÀÌ ÈäºÎº´¿øÀº Áß±¹ ȯÀÚÀÇ ½ÉÀüµµ ¸ð´ÏÅ͸µ°ú Áõ»ó »ó°ü°ü°è¸¦ °ÈÇÏ´Â ICMÀ» Ãâ½ÃÇß½À´Ï´Ù.
The global wireless cardiac monitoring systems market was valued at USD 2.98 billion in 2023 and is expected to grow at a CAGR of 11.4% from 2024 to 2032. Wireless cardiac monitoring systems, comprising wearable sensors and mobile apps, continuously monitor a patient's heart activity and wirelessly transmit the data to healthcare providers. These systems are pivotal in detecting arrhythmias, managing chronic heart conditions, and monitoring post-surgical recovery, thus improving patient outcomes and minimizing the need for frequent hospital visits.
The market is poised for significant growth due to an aging population susceptible to cardiovascular diseases (CVDs), technological advancements in remote monitoring technologies, and increasing product approvals in developed economies. For instance, the British Heart Foundation reported that the prevalence of heart & circulatory diseases globally was 620 million in 2021, with atrial fibrillation accounting for approximately 10% of these cases. Innovations in remote patient monitoring technology are expected to propel the market forward. Industry players are forming strategic alliances, such as funding and collaborations, to develop vendor-neutral cardiac data management platforms. These platforms enable the monitoring of medical information from implantable cardiac monitors (ICM), wearable devices, consumer ECG devices, and more. Moreover, integrating artificial intelligence (AI) into these platforms, which synchronizes electronic health records and identifies urgent patient reports and critical heart rhythms, is expected to drive market growth. For example, in July 2023, PaceMate, a remote cardiac monitoring service provider, secured investment from Lead Edge Capital to enhance its cardiac solutions and demographic reach.
North America dominated the global wireless cardiac monitoring systems market, accounting for 48.53% of the total market share in 2023. This dominance is attributed to the region's advanced healthcare infrastructure, high prevalence of cardiovascular diseases, rapid technological advancements, substantial healthcare expenditure, and an increasing geriatric population. According to the Rural Health Information Hub, the U.S. geriatric population is expected to rise by 18 million between 2020-2030, with 90% of adults over 65 developing one or more chronic conditions. Moreover, Asia-Pacific is projected to witness the fastest CAGR of 13.5% over the forecast period. The growth is driven by increasing product approvals in countries like China and Japan. For instance, in January 2020, Biotronik SE & Co. KG launched its implantable cardiac monitor (ICM), BioMonitor III, in Japan to help healthcare professionals identify underlying arrhythmias. Similarly, in October 2021, Shanghai Chest Hospital launched an ICM to enhance ECG monitoring & symptom correlation for Chinese patients.